HomeInsightsBoard of Directors

Glaxosmithkline Consumer Healthcare Ltd(merged) Board of Directors

Glaxosmithkline Consumer Healthcare Ltd(merged) Board of Directors

stocks purchased

₹ 2.7 Cr

Volume transacted

stocks purchased

2.5 K

stocks traded

Last Updated time: 19 Sep 9.00 AM

Board of Directors

name
leftdesignationleft
Kunal KashyapIndependent Director
Naresh DayalIndependent Director
P DwarakanthChairman
Sangeeta TalwarIndependent Director
Shanu SaksenaCompany Secretary

Key Highlights

  • Kunal Kashyap joins the board as Independent Director, in a new position in 2019. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
  • Naresh Dayal joins the board as Independent Director, in a new position in 2019. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
  • P Dwarakanth joins the board as Chairman, in a new position in 2019. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
  • Sangeeta Talwar joins the board as Independent Director, in a new position in 2019. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
  • Shanu Saksena joins the board as Company Secretary, in a new position in 2019. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
Image

GlaxoSmithkline Consumer Healthcare Ltd(Merged)

NSE: GSKCONS

PRICE

stock direction

Last updated:

Last Ten Days Share Price

Date
leftPriceleft
15 Apr 202010753.65
13 Apr 202010232.35
09 Apr 202010365.65
08 Apr 202010615.25
07 Apr 202010590.7
03 Apr 20209367.15
01 Apr 20209548.3
31 Mar 20209993.1
30 Mar 20209452.1
27 Mar 20209413.55

Share price Over Time

1M

1Y

3Y

5Y

Monitoring GlaxoSmithkline Consumer Healthcare Ltd(Merged) share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

GlaxoSmithkline Consumer Healthcare Ltd(Merged) News Hub

News

Board of GlaxoSmithkline Consumer Healthcare takes on record sanction of scheme of merger

The Board of GlaxoSmithkline Consumer Healthcare at its meeting held on 01 April 2020 has ...

Read more

01 Apr 202012:47

News

GlaxoSmithkline Consumer Healthcare to convene board meeting

GlaxoSmithkline Consumer Healthcare will hold a meeting of the Board of Directors of the C...

Read more

17 Mar 202010:43

News

GlaxoSmithkline Consumer Healthcare to convene board meeting

GlaxoSmithkline Consumer Healthcare will hold a meeting of the Board of Directors of the C...

Read more

13 Jan 202016:32

News

GlaxoSmithkline Consumer Healthcare to announce Quarterly Result

GlaxoSmithkline Consumer Healthcare will hold a meeting of the Board of Directors of the C...

Read more

15 Oct 201910:38

News

GlaxoSmithkline Consumer Healthcare Ltd up for third straight session

GlaxoSmithkline Consumer Healthcare Ltd is up for a third straight session today. The stoc...

Read more

17 Sep 201913:05

News

GlaxoSmithkline Consumer Healthcare Ltd gains for third straight session

GlaxoSmithkline Consumer Healthcare Ltd gained for a third straight session today. The sto...

Read more

22 Aug 201913:05

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for Board of Directors of GlaxoSmithkline Consumer Healthcare Ltd(Merged)

How are members of GlaxoSmithkline Consumer Healthcare Ltd(Merged) Board of Directors selected?

Members of the GlaxoSmithkline Consumer Healthcare Ltd(Merged) Board of Directors are typically selected based on their expertise, experience, and alignment with GlaxoSmithkline Consumer Healthcare Ltd(Merged)’s strategic goals. Appointments are made by the nomination and remuneration committee and approved by shareholders. However, the selection process does vary from company to company.

Can shareholders interact with the GlaxoSmithkline Consumer Healthcare Ltd(Merged) Board of Directors?

Shareholders can interact with the GlaxoSmithkline Consumer Healthcare Ltd(Merged) Board of Directors during the Annual General Meeting (AGM) and through formal communications or queries submitted to the company wherein they have the opportunity to ask questions and provide feedback on the business. Please note different companies have different protocols for shareholders who want to meet the Board of Directors.

How often does the GlaxoSmithkline Consumer Healthcare Ltd(Merged) Board of Directors meet?

The GlaxoSmithkline Consumer Healthcare Ltd(Merged) Board of Directors typically meets quarterly. However, special meetings may be summoned as needed to address urgent matters. The frequency can vary depending on business needs and regulatory requirements to ensure ongoing oversight and strategic guidance for the company. A scheduled meeting among the Board of Directors may vary from company to company.

What are the responsibilities of the GlaxoSmithkline Consumer Healthcare Ltd(Merged) Board of Directors?

The GlaxoSmithkline Consumer Healthcare Ltd(Merged) Board of Directors is responsible for setting strategic goals, overseeing company performance, ensuring effective governance, and safeguarding shareholder interests. They provide high-level guidance on corporate policies and risk management. Additionally, they appoint and evaluate senior management and ensure compliance with legal and regulatory requirements. Please note the roles and responsibilities of the Board of Directors may be different from company to company.

Who are the current members of the Board of Directors at GlaxoSmithkline Consumer Healthcare Ltd(Merged)?

The current Board of Directors at GlaxoSmithkline Consumer Healthcare Ltd(Merged) includes Kunal Kashyap( Independent Director) ,Naresh Dayal( Independent Director) ,P Dwarakanth( Chairman) ,Sangeeta Talwar( Independent Director) ,Shanu Saksena( Company Secretary) . The full list can be found on GlaxoSmithkline Consumer Healthcare Ltd(Merged)’s official website or recent corporate filings.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*